Healthcare Denmark’s Post

The population of Croatia is declining, and by the end of the decade almost one third of Croatians will be older than 65. We are living longer, but significantly lower number of healthy years compared to the EU average. Croatian healthcare system lags in funding and in opportunities, and new healthcare challenges push us to quicker and more innovation-focused responses. The panel discussion "The Way Forward: How Social Changes Impact Health Needs for 2030?" will address how this challenging environment shapes the purpose of the healthcare system and whether we are doing enough to spark essential conversations about the future and the technology we need to start using. Panelists: ‣ Ena Vitlov, AstraZeneca, Business Unit Manager BioPharmaceuticals ‣ Maja Vajagić, MD, Andrija Stampar Teaching Institute of Public Health, Specialist in public health medicine ‣ Prof. Ivica Luksic, MD, PhD, Dubrava Clinical Hospital, Director ‣ Dražen Jurković, MD, Specialist in Public Health, M.Sc., The Association of Employers in Healthcare in Croatia (UPUZ-HR), Director ‣ Vesna Stefancic Martic, MD, Public Health Committee, President, Croatian Medical Chamber, Executive Board Member The panel will be moderated by Mario Dukarić, Director of Val grupa. 👉🏻 Join us on June 6-7 at Pavilion 13, Zagreb Fair! Val grupa #HealthCommForum #HCF #Healthcare

🌏 Tackling Diabetes in SEA with Danish Innovation Another fulfilling week of fostering relationship with both Danish organisations and stakeholders in Singapore🇩🇰🇸🇬 📊 Here are facts about the state of our health: 👩⚕️Diabetes treatment varies in Southeast Asia. Some countries have robust healthcare systems, which sees prevention, diagnosis and treatment readily available while others have varying access to treatment within a province. Singapore has the former. Yet, it is estimated that there will be an increase of 50% in diabetic residents above 40 by 2030, up from 400,000 in 2023📈 \ https://lnkd.in/eaW_EbBB. Over the last decade, measures by Singapore government in its fight against diabetes include: 🔹 advocating and educating its population to take onus of one’s health, 🔹 strengthening the healthcare infrastructure to increase accessibility and affordability of treatment for chronic illnesses, 🔹 access to free exercise programs, 🔹 mandating the labelling of drinks based on their sugar and saturated fat content. 📆 World Diabetes Day falls on 14 November 2024. The battle against diabetes must continue not only in Singapore but also around the world. 🤝The Novo Nordisk team shared with Ambassador Jakob Brix Tange and Deputy Head of Mission Rasmus Bjørnø how their organisations tackle the above alarming health issues. They are dedicated to contribute to local communities in Singapore and Southeast Asia. As a responsible Danish organisation, Novo Nordisk looks internally at upholding a good work culture for employees; externally, how it can bring positive impacts to communities, value-chains and mother earth (turning waste to furnishing)! 🌱♻️ If you are a Danish health and medtech organisation and would like to explore market opportunities in Singapore, please contact Chin Ee CHAI, Senior Commercial Advisor. Anand Shetty, Nanna Liborius Sjørup, Carolin Charlotte Blobel #Diabetes #NovoNordisk #DenmarkinSingapore #StrategicHub #Denmark #Singapore #SoutheastAsia #GreenTogether #HealthcareInnovation #DiabetesAwareness #PublicHealth #SustainableHealthcare #DiabetesPrevention #SingaporeHealth #HealthPartnerships #NovoNordisk #MedTechSolutions #WorldDiabetesDay #DanishInnovation

This week GLOHRA Director Nora Anton advocated for continued government support of global health initiatives in the sub-committee (Unterausschuss) meeting on global health. Here's some key highlights: 🔸 Importance of support for interdisciplinary research: Continued governmental incentives are crucial to promote research that crosses disciplinary and sector boundaries, fostering career development and collaboration. See the related GLOHRA policy brief on this topic: https://lnkd.in/drhHkQ3d 🔸 Partnerships with collaborators in LMICs: A call for revising funding regulations to ensure equitable partnerships with institutions in low- and middle-income countries (LMICs) was emphasized. Models that allow direct access to funding for these institutions would strengthen global research collaboration. See the related GLOHRA policy brief on this topic: https://lnkd.in/di9r6ur6 🔸 Operationalization of strategy goals: The need for clear goals and measurable indicators was highlighted to effectively evaluate the success of the Global Health Strategy and adapt as needed. Complex health problems require sustainable solutions through international, interdisciplinary, and cross-sector collaboration. Initiatives such as GLOHRA and the Global Health Hub Germany foster this networking, benefiting both global and local health. 📄 Read the full statement here: https://lnkd.in/eX6FvTVR 📽 Watch the recorded session (GLOHRA part starts at 1:07:06): https://lnkd.in/ehkypajb #globalhealth #research #interdisciplinary #equitablepartnerships #bundestag #parliament #policy #science #sciencepolicy Deutscher Bundestag Andrew Ullmann Helge Braun Knut Gerschau Tina Rudolph Georg Kippels Kordula Schulz-Asche Johannes Wagner Dr. Karamba Diaby Dr. Franziska Kersten Jan-Thilo Klimisch VENRO Nora Anton German Alliance for Global Health Research (GLOHRA) Corinna Heineke Global Health Hub Germany

🌟 Thrilled to share our CEO's reflections from the recent healthcare infrastructure workshop! We're energized to contribute to the transformation of Romania's healthcare sector. Let's quench more than thirst—let's elevate healthcare standards! 🚀 #HealthcareInnovation #IndustryInsights #FilteredWaterLeaders #PublicHealthcareRevolution #ElkayRomania #PhoenixEnvironmental #Apacareitidaviata

Proud to have Julian Rozenberg from Agence de l'innovation en santé visit us ! Launched in June 2021 by the President of the Republic as part of the Health Innovation 2030 plan and led by Lise ALTER, the Health Innovation Agency (AIS) is tasked with piloting and coordinating measures to promote innovations with a positive impact on patient health in France. 🎯 12 priority tasks are structured around 5 levers: Anticipating innovations and medical needs to guide public policies. Facilitating, accelerating, and simplifying the journey of an innovation, from its conception to its availability to patients. Supporting innovative project leaders at each stage of their journey. Investing to make France the leading innovative and sovereign European nation in health. Integrating prevention as a pivot for scaling up positive health outcomes for the French population.

Proud to have Julian Rozenberg from Agence de l'innovation en santé visit us ! Launched in June 2021 by the President of the Republic as part of the Health Innovation 2030 plan and led by Lise ALTER, the Health Innovation Agency (AIS) is tasked with piloting and coordinating measures to promote innovations with a positive impact on patient health in France. 🎯 12 priority tasks are structured around 5 levers: Anticipating innovations and medical needs to guide public policies. Facilitating, accelerating, and simplifying the journey of an innovation, from its conception to its availability to patients. Supporting innovative project leaders at each stage of their journey. Investing to make France the leading innovative and sovereign European nation in health. Integrating prevention as a pivot for scaling up positive health outcomes for the French population.

🤩 On May 23, Steven Vandeput, PhD. will represent our federation at Radical Health Festival Helsinki, a 3-day event bringing together people, data, and innovations to help scale prevention and precision in European healthcare. Steven will participate in a panel on the #reimbursement and adoption of #digitalhealth technologies, alongside experts from five other countries: Germany, France, Italy, Spain, and, of course Finland. 🖤💛❤ During the panel, special attention will be given to three countries: France with its #PECAN model, Germany with #DiGA, and ... Belgium with our reimbursement framework for #mhealth solutions. Something to be proud of, being a small country in Europe. And at the same time, an encouragement to do even better? 💪 In any case, we are convinced Belgium can become a frontrunner in the use of innovative digital medical technologies to support healthcare providers and patients. That is if we dare to think radically outside the box from time to time. Also on our agenda in Finland? 👉 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝗶𝗻𝗴 𝗼𝘂𝗿 𝗰𝗼𝗻𝘁𝗮𝗰𝘁𝘀 with experts from Germany, France, and other European countries. 👉 𝗚𝗮𝗶𝗻𝗶𝗻𝗴 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗮𝗻𝗱 𝗸𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 that we can bring back to Belgium to share with policymakers, our members, and other healthcare stakeholders. 👉 𝗦𝗵𝗮𝗿𝗶𝗻𝗴 𝗼𝘂𝗿 𝗹𝗲𝘀𝘀𝗼𝗻𝘀 𝗹𝗲𝗮𝗿𝗻𝗲𝗱 with #mHealthBelgium with stakeholders from other countries. 𝗣.𝗦. Outside the festival, we will also meet with Finnish authorities to discuss the #digitalhealth story we are writing in Belgium (among other topics). Looking forward already! 👁 #RadicalHealth #DigitalInHealth #medtechmatters #healthcareinnovation #digitalhealth RIZIV FOD Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu Agoria

Saving lives is my motivation.

Have you heard the news? ✨ We’re thrilled to announce that our very own Merilin Varsamaa has been selected as the sole expert from Estonia to join the World Health Organization's (WHO) Public Health Innovation Advisory Group! Merilin will be part of a team of 15 top specialists from across the globe, working together to address some of the most pressing health challenges in the WHO European region. The WHO European Region faces complex health challenges: from the global spread of infectious diseases like COVID-19 and influenza to chronic illnesses such as heart disease, cancer, and diabetes, as well as rising mental health issues. These challenges are worsened by an aging population and unequal access to healthcare. Yet, the region holds immense untapped potential. Merilin sees this as a unique opportunity to champion Estonia’s innovative ecosystem on a global stage: “Public health innovation directly impacts well-being, extending healthy life years and contributing to economic growth. I’m honoured to bring Estonia’s perspective to the table and support the development of world-changing technologies. By applying WHO’s ‘Health in All Policies’ strategy, we can ensure that health considerations are integrated into all sectors.” For Estonia, this role is also a gateway to ensuring that our innovative solutions contribute to addressing global health problems. 🇪🇪 The first advisory board meeting will take place on November 28, kicking off a two-year journey toward shaping sustainable innovation ecosystems that cater to the evolving health needs of populations across Europe. Congratulations, Merilin! 👏 We can’t wait to see the impact of your work in advancing public health innovation. #TehnopolHealthTech #WHO #PublicHealthInnovation #HealthInnovation

🗓️  2️⃣2️⃣ 0️⃣5️⃣ 🌟The next CEO Breakfast 🌟 brought to you by the German Hungarian Chamber of Industry and Commerce AHK Ungarn - DUIHK - Német-Magyar Ipari és Kereskedelmi Kamara and the BBJ - Budapest Business Journal, will focus on a subject that affects us all, both personally and as employers, whether working directly in the sector or not: #healthcare. ⚕🩺️🏥 Our expert panel will include 🔹Dr Judit Bidló, Deputy State Secretary at the Ministry of Interior, responsible for healthcare; 🔹Dr Ádám Nagy, Deputy State Secretary for Industry Affairs, Ministry for National Economy, responsible for strategic planning; and 🔹Dr Tamas Radai of the Association of Health Technology Suppliers and Medical Device Manufacturers (etosz). The CEO Breakfast will explore Hungary's healthcare and pharma landscape and the new industrial strategy for the sector recently outlined by the Ministry of National Economy. According to the State of Health in the EU Hungary Country Health Profile 2023, spending on health in Hungary is among the lowest in the EU, with only Croatia, Slovakia, Poland, Bulgaria and Romania behind it. The numbers of doctors and nurses are below the EU average. Hungary spends less per capita than the EU average in all healthcare categories (total spending, inpatient care, outpatient care, pharmaceutical and medical devices, prevention, long-term care, administration and others). If you find this event interesting and would like to participate, please don't hesitate to register here at DUIHK's website: https://lnkd.in/d2QUcKQz #CEOBreakfast #Healthcare #IndustryInsights #HungaryHealthcare #DUIHK #BudapestBusinessJournal